Sugentech, the South Korean medical diagnostics company has already begun mass production of its antibody-based testing kits for COVID-19. The rapid test kit has already completed its registration with the FDA and is approved under the FDA’s Emergency Use Authorization (EUA). The company also acquired CD-IVD certification for shipment of product in European countries.
Utilizing Apache Commodities for distribution, the Sugentech Testing Kits are available for any individual or organization with enough inventory to meet growing demands.
SGTI-flex COVID-19 IgG/IgM
Sugentech’s fast testing kit can detect infection within 10 minutes without a trained analyzer or analysis equipment. The SGTi-flex COVID-19 IgG/IgM is a gold nanoparticle-based immunochromatographic test kit for qualitative determination of COVID-19’s IgM and IgG antibodies in human blood, serum, or plasma. The test works with a blood sample with a low sample risk, as in the molecular diagnostic method (RT-PCR).
The diagnostic accuracy of fast testing kits reached 94.4 percent after a large-scale clinical trial in Daequ hospital involving 250 specimens. With the RT-PCR assay, health professionals could accurately detect and analyze even the tiniest amount of coronavirus.
Visit http://www.apachecommodities.com or call (888) 440-0092 for more information today.